REGN: third_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/955bc36a-d1d3-4f29-af94-7b03892b9338/","filing_uuid":"955bc36a-d1d3-4f29-af94-7b03892b9338","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/955bc36a-d1d3-4f29-af94-7b03892b9338/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Zach Price","dt_posted":"2026-10-15T14:25:23-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"505 9th Street NW","registrant_address_2":"Suite 830","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":294930,"url":"https://lda.gov/api/v1/registrants/294930/","house_registrant_id":37434,"name":"THE WASHINGTON TAX & PUBLIC POLICY GROUP","description":"​Legislative and regulatory consulting.","address_1":"505 9th Street NW","address_2":"Suite 830","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GREGORY NICKERSON","contact_telephone":"+1 202-534-4949","dt_updated":"2026-10-20T14:56:42.462084-04:00"},"client":{"id":64079,"url":"https://lda.gov/api/v1/clients/64079/","client_id":64079,"name":"REGENERON PHARMACEUTICALS, INC.","general_description":"Biotechnology company.","client_government_entity":null,"client_self_select":false,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-01-01"},"lobbying_activities":[{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to corporate and international taxation. Issues related to OECD Pillar 1 and Pillar 2 negotiations, agreements, implementation, and reporting related to the taxation of global income. Issues related to IRC sections 11, 951A, and 250.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":38177,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"NICKERSON","suffix":null,"suffix_display":null},"covered_position":"Tax Counsel, Ways and Means Committee; Staff Director, Ways and Means Select Revenue Measures Subcommittee","new":false},{"lobbyist":{"id":69617,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":"AUSTIN","last_name":"PRICE","suffix":null,"suffix_display":null},"covered_position":"Staff assistant to Sen. Coats","new":false}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}